Literature DB >> 8012035

Hormone receptors and cathepsin D levels in human breast epithelial cells transformed by chemical carcinogens and c-Ha-ras transfection.

G Calaf1, Q Tahin, M E Alvarado, S Estrada, T Cox, J Russo.   

Abstract

The objective of this work was to determine whether transformation of the human breast epithelial cell line MCF-10F by the chemical carcinogens 7, 12-dimethylbenz(a)anthracene (DMBA) or benzo(a)pyrene (BP), or c-Ha-ras oncogene transfection, influence the expression of epidermal growth factor receptor (EGFR), estrogen (ER) or progesterone (PR) receptors, and the content of cathepsin-D (Cath.D). MCF-10F control cells did not express any of the phenotypes of neoplastic transformation, whereas carcinogen-treated cells and clones derived from the latter formed colonies in agar-methocel, and exhibited increased chemotaxis and chemoinvasion. Clone BP-1E was also tumorigenic in SCID mice. The BP1 cell line transfected with mutated c-Ha-ras oncogene, named BP1-Tras, became more aggressive after transfection and decreased the latency time to tumorigenesis. Radioligand binding and immunocytochemical reactions were utilized for determining the receptors and Cath.D content of control and carcinogen-treated cells and their derived clones. MCF-10F cells contained 37 fmol/mg of protein of EGFR, ER and PR were undetectable, and Cath.D content was 70 fmol/mg protein. EGFR content was significantly higher in D3-1 and BP1-E cell lines vs the control MCF-10F and the other DMBA and BP clones, correlating positively with the emergence of the transformation phenotype. Whereas EGFR levels were not significantly different in BP1-Tras cells when compared with BP1-E, the former were more tumorigenic in SCID mice, an observation suggesting an alternative pathway in these cells in the formation of tumors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012035     DOI: 10.1007/bf00665678

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  39 in total

1.  Modulation by estrogen and growth factors of transforming growth factor-alpha and epidermal growth factor receptor expression in normal and malignant human mammary epithelial cells.

Authors:  D S Salomon; W R Kidwell; N Kim; F Ciardiello; S E Bates; E Valverius; M E Lippman; R B Dickson; M Stampfer
Journal:  Recent Results Cancer Res       Date:  1989

2.  Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors.

Authors:  G J Todaro; C Fryling; J E De Larco
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

3.  Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture.

Authors:  N Kamata; K Chida; K Rikimaru; M Horikoshi; S Enomoto; T Kuroki
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

4.  Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10.

Authors:  L Tait; H D Soule; J Russo
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

5.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.

Authors:  A Ullrich; L Coussens; J S Hayflick; T J Dull; A Gray; A W Tam; J Lee; Y Yarden; T A Libermann; J Schlessinger
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

6.  Transformation of human breast epithelial cells by chemical carcinogens.

Authors:  G Calaf; J Russo
Journal:  Carcinogenesis       Date:  1993-03       Impact factor: 4.944

7.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.

Authors:  T J Velu; L Beguinot; W C Vass; M C Willingham; G T Merlino; I Pastan; D R Lowy
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

8.  Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines.

Authors:  N E Davidson; E P Gelmann; M E Lippman; R B Dickson
Journal:  Mol Endocrinol       Date:  1987-03

9.  Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.

Authors:  S M Thorpe; H Rochefort; M Garcia; G Freiss; I J Christensen; S Khalaf; F Paolucci; B Pau; B B Rasmussen; C Rose
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

10.  Increased EGF receptors on human squamous carcinoma cell lines.

Authors:  G P Cowley; J A Smith; B A Gusterson
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

View more
  4 in total

1.  Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.

Authors:  Travis Young; Fang Mei; Jinsong Liu; Robert C Bast; Alexander Kurosky; Xiaodong Cheng
Journal:  Oncogene       Date:  2005-09-08       Impact factor: 9.867

2.  Cathepsins D, B, and L in transformed human breast epithelial cells.

Authors:  T T Lah; G Calaf; E Kalman; B G Shinde; R Somers; S Estrada; E Salero; J Russo; I Daskal
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 3.  Xenograft models of premalignant breast disease.

Authors:  F R Miller
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

Review 4.  ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches.

Authors:  Jin-Qiang Chen; Jose Russo
Journal:  Biochim Biophys Acta       Date:  2009-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.